Update research from QuotedData

RNS Number : 6504S
India Capital Growth Fund Limited
26 June 2018
 

India Capital Growth - Update research from QuotedData

 

26th June 2018

 

A return to earnings growth

 

Earnings figures for the companies in India Capital Growth (IGC)'s portfolio are increasing as India puts the disruptive effects of demonetisation and the introduction of the Goods and Services Tax (GST) - both of which were covered in QuotedData's March 2017 note - behind it. Rising oil prices may be a headwind but India's domestically focused economy should be relatively sheltered from a global trade war. Gaurav Narain, investment adviser to IGC, thinks we could see the companies in IGC's portfolio reporting average earnings growth of at least 20% a year for the periods ending March 2019 and March 2020.

 

Full research:

https://quoteddata.com/2018/06/india-capital-growth-return-earnings-growth/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on India Capital Growth Fund and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

QUOTEDDATA
123a Kings Road | London SW3 4PL
Tel: +44 (0) 20 3691 9430

www.quoteddata.com com 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUNRSRWRANUAR
UK 100

Latest directors dealings